1-7 of 7
Lisbeth A. Guethlein
Close
Sort by
Journal Articles

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Zachary B. Davis, PhD, Frank Cichocki, PhD, Martin Felices, PhD, Rose Wangen, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Claudio Brunstein, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Amir Horowitz, Lisbeth A Guethlein, Peter Parham, PhD, Michael R. Verneris, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2014) 124 (21): 181.
https://doi.org/10.1182/blood.V124.21.181.181
Published: 2014
Journal Articles

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

Sarah Cooley, MD, Daniel J. Weisdorf, MD, Lisbeth A Guethlein, John P Klein, PhD, Tao Wang, PhD, Steve G.E. Marsh, Stephen Spellman, MBS, Michael D Haagenson, MS, Koy Saeturn, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller, MD
Journal: Blood
Blood (2013) 122 (21): 549.
https://doi.org/10.1182/blood.V122.21.549.549
Published: 2013
Journal Articles

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

Clinical Trials & Observations
Sarah Cooley, Daniel J. Weisdorf, Lisbeth A. Guethlein, John P. Klein, Tao Wang, Chap T. Le, Steven G. E. Marsh, Daniel Geraghty, Stephen Spellman, Michael D. Haagenson, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller
Journal: Blood
Blood (2010) 116 (14): 2411–2419.
https://doi.org/10.1182/blood-2010-05-283051
Published: 2010
Journal Articles

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, Daniel J. Weisdorf
Journal: Blood
Blood (2009) 113 (3): 726–732.
https://doi.org/10.1182/blood-2008-07-171926
Published: 2009
Includes: Supplemental data
Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD
Journal: Blood
Blood (2007) 110 (11): 43.
https://doi.org/10.1182/blood.V110.11.43.43
Published: 2007
Journal Articles

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

Sarah Cooley, Feng Xiao, Michelle Pitt, Michelle Gleason, Valarie McCullar, Tracy L. Bergemann, Karina L. McQueen, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller
Journal: Blood
Blood (2007) 110 (2): 578–586.
https://doi.org/10.1182/blood-2006-07-036228
Published: 2007
Includes: Supplemental data
Journal Articles

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

Brief Report
Jeffery S. Miller, Sarah Cooley, Peter Parham, Sherif S. Farag, Michael R. Verneris, Karina L. McQueen, Lisbeth A. Guethlein, Elizabeth A. Trachtenberg, Michael Haagenson, Mary M. Horowitz, John P. Klein, Daniel J. Weisdorf
Journal: Blood
Blood (2007) 109 (11): 5058–5061.
https://doi.org/10.1182/blood-2007-01-065383
Published: 2007